Cargando…

Atezolizumab‐induced fulminant type 1 diabetes mellitus occurring four months after treatment cessation

Atezolizumab is an immune checkpoint inhibitor (ICI) that is often associated with the development of several immune‐related adverse events, including fulminant type 1 diabetes mellitus (F1DM). Here, we present the case of a 73‐year‐old woman who was diagnosed with lung adenocarcinoma after surgical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishioki, Toshihiko, Kato, Motoyasu, Kataoka, Shunichi, Miura, Keita, Nagaoka, Tetsutaro, Takahashi, Kazuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666772/ https://www.ncbi.nlm.nih.gov/pubmed/33224504 http://dx.doi.org/10.1002/rcr2.685

Ejemplares similares

Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma
por: Ikeda, Munehiro, et al.
Publicado: (2022)

Bevacizumab‐induced chronic interstitial pneumonia during maintenance therapy in non‐small cell lung cancer
por: Sekimoto, Yasuhito, et al.
Publicado: (2016)

Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study
por: Kato, Motoyasu, et al.
Publicado: (2019)

Severe mediastinitis over a month after endobronchial ultrasound‐guided transbronchial needle aspiration
por: Kurokawa, Kana, et al.
Publicado: (2019)

Fulminant Marginal Keratitis Induced by Atezolizumab, a Programmed Death Ligand 1 Inhibitor for Lung Cancer
por: Yamamoto, Masashi, et al.
Publicado: (2023)

Idiopathic dendriform pulmonary ossification diagnosed by bronchoscopic lung cryobiopsy: A case report
por: Sekimoto, Yasuhito, et al.
Publicado: (2021)

Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment
por: Charville, Gregory W., et al.
Publicado: (2018)

Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination
por: Rolfes, Leoni, et al.
Publicado: (2019)

Fulminant type 1 diabetes mellitus in pregnancy
por: Li, Chun-Yu, et al.
Publicado: (2020)

Two cases of unresectable hepatocellular carcinoma treated via atezolizumab and bevacizumab combination therapy
por: Tsunemitsu, Ryosuke, et al.
Publicado: (2023)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Refractory Fulminant Colitis Requiring Surgical Intervention in a Patient With Ulcerative Colitis on Atezolizumab Therapy for Small Cell Lung Cancer: An Atypical Case
por: Steiger, Stephanie, et al.
Publicado: (2022)

Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report
por: Kato, Motoyasu, et al.
Publicado: (2021)

Anaphylaxis to three humanized antibodies for severe asthma: a case study
por: Jingo, Koichi, et al.
Publicado: (2020)

Fulminant type 1 diabetes mellitus: Two case reports
por: You, Wei, et al.
Publicado: (2019)

Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience
por: Ogawa, Keita, et al.
Publicado: (2022)

Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma
por: Nishioki, Toshihiko, et al.
Publicado: (2022)

Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment
por: Hatayama, Satoko, et al.
Publicado: (2022)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

Pan-vasculitis and fulminant hepatitis following routine vaccination at the age of 4 months
por: Awad, Mohammad Hosny, et al.
Publicado: (2021)

Fulminant subacute sclerosing panencephalitis in an immunized 20-month-old Indian boy
por: Al-Mendalawi, Mahmood D.
Publicado: (2019)

Fulminant subacute sclerosing panencephalitis in an immunized 20-month-old Indian boy
por: Khursheed, Ahmad, et al.
Publicado: (2018)

Pneumatosis intestinalis with free air in the abdominal cavity caused by nintedanib
por: Sakamoto, Naho, et al.
Publicado: (2023)

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer
por: Kataoka, Nobutaka, et al.
Publicado: (2020)

Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
por: Ahmed, Faiza, et al.
Publicado: (2021)

Results of an Inpatient Smoking Cessation Program: 3-Month Cessation Rate and Predictors of Success
por: Kim, Sun-Hee, et al.
Publicado: (2015)

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients
por: Kondo, Takayuki, et al.
Publicado: (2023)

Nonocclusive mesenteric ischemia: fulminant pancolitis
por: Kato, Kazuya, et al.
Publicado: (2016)

Development of Fulminant Type 1 Diabetes Mellitus in a Patient with DRESS Syndrome
por: Perez, Pedro, et al.
Publicado: (2020)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral
por: Kusuki, Kazuhisa, et al.
Publicado: (2020)

Prolonged Survival in a Patient With Extensive-Stage Small Cell Lung Cancer in Spite of Discontinued Immunotherapy With Atezolizumab
por: Konishi, Kazuhisa, et al.
Publicado: (2023)

Case Report: Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants
por: Totsune, Eriko, et al.
Publicado: (2021)

Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report
por: Kato, Yukari, et al.
Publicado: (2020)

Two Cases of Atezolizumab-Induced Hypophysitis
por: Kanie, Keitaro, et al.
Publicado: (2017)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Lambert, Nicolas, et al.
Publicado: (2022)

Fulminant isolated adenovirus hepatitis 5 months after haplo-identical HSCT for AML
por: Detrait, Marie, et al.
Publicado: (2015)

Fulminating Appendicitis
Publicado: (1901)

Fulminant meningococcemia
por: Fidrocki, Diana, et al.
Publicado: (2017)

Fulminant hepatitis
por: Sinclair, Stephen, et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_gna1n5eomd4cj62ss9bleu6gfo